Transforming growth factor beta 1 is present at sites of extracellular matrix gene expression in human pulmonary fibrosis
- PMID: 1862087
- PMCID: PMC52144
- DOI: 10.1073/pnas.88.15.6642
Transforming growth factor beta 1 is present at sites of extracellular matrix gene expression in human pulmonary fibrosis
Abstract
Idiopathic pulmonary fibrosis is an inexorably fatal disorder characterized by connective tissue deposition within the terminal air spaces resulting in loss of lung function and eventual respiratory failure. Previously, we demonstrated that foci of activated fibroblasts expressing high levels of fibronectin, procollagen, and smooth muscle actin and thus resembling those found in healing wounds are responsible for the connective tissue deposition and scarring in idiopathic pulmonary fibrosis. Using in situ hybridization and immunohistochemistry, we now demonstrate the presence of transforming growth factor beta 1 (TGF-beta 1), a potent profibrotic cytokine, in the foci containing these activated fibroblasts. These results suggest that matrix-associated TGF-beta 1 may serve as a stimulus for the persistent expression of connective tissue genes. One potential source of the TGF-beta 1 is the alveolar macrophage, and we demonstrate the expression of abundant TGF-beta 1 mRNA in alveolar macrophages in lung tissue from patients with idiopathic pulmonary fibrosis.
Similar articles
-
The potential role of PDGF, IGF-1, TGF-beta expression in idiopathic pulmonary fibrosis.Chin Med J (Engl). 2000 Sep;113(9):776-82. Chin Med J (Engl). 2000. PMID: 11776068
-
Transforming growth factors-beta 1, -beta 2, and -beta 3 stimulate fibroblast procollagen production in vitro but are differentially expressed during bleomycin-induced lung fibrosis.Am J Pathol. 1997 Mar;150(3):981-91. Am J Pathol. 1997. PMID: 9060836 Free PMC article.
-
Analysis of local mRNA expression for extracellular matrix proteins and growth factors using in situ hybridization in fibroproliferative lung disorders.Chest. 1991 Mar;99(3 Suppl):55S-56S. doi: 10.1378/chest.99.3_supplement.55s. Chest. 1991. PMID: 1997276 No abstract available.
-
How is Type I procollagen synthesis regulated at the gene level during tissue fibrosis.J Cell Biochem. 2003 Sep 1;90(1):1-5. doi: 10.1002/jcb.10599. J Cell Biochem. 2003. PMID: 12938150 Review.
-
The molecular basis of interstitial pulmonary fibrosis caused by antineoplastic agents.Cancer Treat Rev. 1990 Sep;17(2-3):165-7. doi: 10.1016/0305-7372(90)90042-e. Cancer Treat Rev. 1990. PMID: 1703044 Review. No abstract available.
Cited by
-
Emerging pharmacological options in the treatment of idiopathic pulmonary fibrosis (IPF).Expert Rev Clin Pharmacol. 2024 Sep;17(9):817-835. doi: 10.1080/17512433.2024.2396121. Epub 2024 Aug 27. Expert Rev Clin Pharmacol. 2024. PMID: 39192604 Review.
-
Interstitial Lung Diseases and Non-Small Cell Lung Cancer: Particularities in Pathogenesis and Expression of Driver Mutations.Genes (Basel). 2024 Jul 17;15(7):934. doi: 10.3390/genes15070934. Genes (Basel). 2024. PMID: 39062713 Free PMC article. Review.
-
Defining the mechanism of galectin-3-mediated TGF-β1 activation and its role in lung fibrosis.J Biol Chem. 2024 Jun;300(6):107300. doi: 10.1016/j.jbc.2024.107300. Epub 2024 Apr 18. J Biol Chem. 2024. PMID: 38641066 Free PMC article.
-
TGF-β signaling in health, disease, and therapeutics.Signal Transduct Target Ther. 2024 Mar 22;9(1):61. doi: 10.1038/s41392-024-01764-w. Signal Transduct Target Ther. 2024. PMID: 38514615 Free PMC article. Review.
-
Interstitial Lung Disease in Rheumatoid Arthritis: A Review.Cureus. 2024 Feb 5;16(2):e53632. doi: 10.7759/cureus.53632. eCollection 2024 Feb. Cureus. 2024. PMID: 38449991 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical